ILC3-derived IL-22 can facilitate intestinal epithelial restitution after tissue destruction via inducing cell proliferation and maintaining intestinal epithelial stem cells (ISCs), which might be involved in injury reduction of colitis and other intestinal inflammatory diseases [9], [10], [11]. This evidence concerns the gene IL22 and colitis.